Kymab Group Limited (Companies House Registration Number 10414057) is a private limited company founded on 2016-10-06 in United Kingdom. This company is located at The Bennet Building (B930), Babraham Research Campus, Cambridge CB22 3AT. Kymab Group Limited is operating under SIC code: 82990 which stands for "other business support service activities not elsewhere classified".

Company details

Name Kymab Group Limited
Number 10414057
Date of Incorporation: October 6, 2016
End of financial year: 31 December
Address: The Bennet Building (b930), Babraham Research Campus, Cambridge, CB22 3AT
SIC code: 82990 - Other business support service activities not elsewhere classified

Moving on to the 2 directors that can be found in the above-mentioned firm, we can name: Usman K. (appointed on 01 August 2021), Gordon T. (appointment date: 01 August 2021). The official register indexes 3 persons of significant control, namely: Sanofi can be found at Avenue De La Grande Armée, 75017 Paris. This corporate PSC owns over 3/4 of shares, 3/4 to full of voting rights. The Wellcome Trust Limited (As Trustee Of The Wellcome Trust) can be found at 215 Euston Road, NW1 2BS London. This corporate PSC owns 1/2 or less of shares, 1/2 or less of voting rights. David C. owns over 3/4 of shares, 3/4 to full of voting rights.

Directors

People with significant control

Sanofi
8 April 2021
Address 46 Avenue De La Grande Armée, Paris, 75017, France
Legal authority French
Legal form Limited Company
Country registered France
Place registered Nasdaq Global Select Market
Registration number Fr0000120578
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors
The Wellcome Trust Limited (As Trustee Of The Wellcome Trust)
23 November 2016 - 8 April 2021
Address Gibbs Building 215 Euston Road, London, NW1 2BS, United Kingdom
Legal authority Companies Act 2006
Legal form Private Company Limited By Shares
Country registered England
Place registered Companies House England
Registration number 02711000
Nature of control: right to appoint and remove directors
25-50% voting rights
25-50% shares
David C.
6 October 2016 - 23 November 2016
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors

Filings

Categories:
Accounts Capital Confirmation statement Incorporation Insolvency Officers Persons with significant control Resolution
(AA) Full accounts for the period ending Fri, 31st Dec 2021
filed on: 23rd, March 2023 | accounts
Free Download (36 pages)